rimexolone
Selected indexed studies
- Rimexolone. (, 2006) [PMID:29999700]
- Rimexolone-induced intraocular pressure elevation. (Eye (Lond), 2001) [PMID:11702986]
- ** (BioDrugs, 1997) [PMID:18031088]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Rimexolone. (2006) pubmed
- Rimexolone-induced intraocular pressure elevation. (2001) pubmed
- PMID:18031088 (1997) pubmed
- Rimexolone inhibits proliferation, cytokine expression and signal transduction of human CD4+ T-cells. (2010) pubmed
- Intraocular pressure-raising potential of 1.0% rimexolone in patients responding to corticosteroids. (1996) pubmed
- Steroid-induced ocular hypertension in the pediatric age group. (2018) pubmed
- Outcome and risk of ocular complications of managing children with chronic anterior uveitis with topical rimexolone 1. (2020) pubmed
- Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery. (2008) pubmed
- The effects of Rimexolone 1% in postoperative inflammation after cataract extraction. A double-masked placebo-controlled study. (1998) pubmed
- Ocular-hypertensive and anti-inflammatory response to rimexolone therapy in children. (2003) pubmed